Markets
Tendies
@tendies
Bought MBOT
Shares
0.0%
At 1.48, Now 1.48
I'm really optimistic about MBOT as it’s on the verge of FDA approval with strong catalysts lined up. The new leadership changes and the inventory bui...
Read
More
Thesis
I'm really optimistic about MBOT as it’s on the verge of FDA approval with strong catalysts lined up. The new leadership changes and the inventory buildup suggest they're ready for a commercial launch, which could significantly push the stock up. I see this as a solid hold for a swing trade.
Go back
Tendies
@tendies
Bought MBOT
Shares
down -13.7%
At 1.72, Exited 1.48
I'm considering adding to my position in MBOT since it’s down at $1.65, and I believe there's a chance it could rise significantly around the FDA deci...
Read
More
Thesis
I'm considering adding to my position in MBOT since it’s down at $1.65, and I believe there's a chance it could rise significantly around the FDA decision date in 20 days. The potential for approval looks good based on study results, so I see this as a viable swing trade for the upcoming weeks.
Go back
Tendies
@tendies
Bought MBOT
Shares
down -25.2%
At 2.5, Exited 1.87
I just saw the news about the direct stock offering at $1.75 for 7 million shares, and I think the price will dip initially. I'm planning to buy into ...
Read
More
Thesis
I just saw the news about the direct stock offering at $1.75 for 7 million shares, and I think the price will dip initially. I'm planning to buy into MBOT at its low point today, as I believe there's potential for a rebound shortly after.
Go back
Long
@long_gam...
Bought MBOT
Shares
down -32.06%
At 2.62, Exited 1.78
I'm strongly considering buying MBOT as it's significantly undervalued at $2.60, especially with analysts projecting a price target of $8.00. With ant...
Read
More
Thesis
I'm strongly considering buying MBOT as it's significantly undervalued at $2.60, especially with analysts projecting a price target of $8.00. With anticipated FDA approvals on the horizon, the stock could soar to $20-$40, making this a promising swing trade opportunity.
Go back
Tendies
@tendies
Bought MBOT
Shares
down -6.94%
At 2.07, Exited 1.93
I'm feeling optimistic about MBOT's potential for a short squeeze. With the stock being heavily shorted and recent rally momentum, it could drive the ...
Read
More
Thesis
I'm feeling optimistic about MBOT's potential for a short squeeze. With the stock being heavily shorted and recent rally momentum, it could drive the price up significantly. Plus, their new contract for the LIBERTY system opens up more growth opportunities.
Go back
Tendies
@tendies
Bought MBOT
Shares
up 30.7%
At 1.14, Exited 1.49
I just bought more shares of MBOT after seeing their recent FDA submission news. With their ongoing developments and partnerships, I believe this stoc...
Read
More
Thesis
I just bought more shares of MBOT after seeing their recent FDA submission news. With their ongoing developments and partnerships, I believe this stock is set for a significant move upwards once the FDA approves their application in early 2025. It's a great long-term play.
Go back
Tendies
@tendies
Bought MBOT
Shares
up 134%
At 1.21, Exited 2.83
I'm really excited about Microbot Medical as they anticipate launching LIBERTY in Q2 2025 and are also seeking regulatory approvals to boost growth ou...
Read
More
Thesis
I'm really excited about Microbot Medical as they anticipate launching LIBERTY in Q2 2025 and are also seeking regulatory approvals to boost growth outside the U.S. With a strong advisory board and a focused team, this stock looks poised for an upward movement.
Go back
Tendies
@tendies
Bought MBOT
Shares
up 110%
At 1.02, Exited 2.14
I'm really excited about MBOT as it’s the first microbot approved for a pivotal study, and if it gets the 510(k) approval coming up in Q2, I think it ...
Read
More
Thesis
I'm really excited about MBOT as it’s the first microbot approved for a pivotal study, and if it gets the 510(k) approval coming up in Q2, I think it could see significant gains. The low market cap and cash position give me more confidence.
Go back
Tendies
@tendies
Bought MBOT
Shares
up 73.94%
At 0.96, Exited 1.67
I'm really excited about Microbot Medical (MBOT) as I believe it's on the verge of significant growth with its revolutionary LIBERTY™ System. The comb...
Read
More
Thesis
I'm really excited about Microbot Medical (MBOT) as I believe it's on the verge of significant growth with its revolutionary LIBERTY™ System. The combination of innovative technology and the potential for regulatory approvals leads me to think that MBOT could capture a large share of the robotic medical device market by 2025 and beyond.
Go back
Tendies
@tendies
Bought MBOT
Shares
up 5.26%
At 0.95, Exited 1.0
I believe Microbot Medical is on the verge of a major breakthrough with their robotic endovascular system, especially after their successful clinical ...
Read
More
Thesis
I believe Microbot Medical is on the verge of a major breakthrough with their robotic endovascular system, especially after their successful clinical trial. With upcoming FDA approval, this could set the stage for a significant increase in stock value as they prepare to enter the market.
Go back
